ProfileGDS5822 / ILMN_2492956
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 34% 2% 12% 14% 5% 28% 45% 0% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.534
GSM1276600PDAC Late Ablation Control 27.82
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.512
GSM1276603PDAC Late Ablation 210.114
GSM1276604PDAC Late Ablation 35.65
GSM1303940PDAC Late Ablation_anti-CTLA4 114.828
GSM1303941PDAC Late Ablation_anti-CTLA4 221.945
GSM1303942PDAC Late Ablation_anti-CTLA4 30.50